Title : [Therapeutic development for GNE myopathy.]

Pub. Date : 2017

PMID : 28232658






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 GNE gene, which encodes for a key enzyme in the sialic acid biosynthesis pathway, is mutated in the homozygote or compound heterozygote in the disease. N-Acetylneuraminic Acid glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Mus musculus
2 The lack of sialic acid in skeletal muscle is the critical pathological process in GNE myopathy. N-Acetylneuraminic Acid glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Mus musculus
3 GNE myopathy model mouse was established and supplementation of sialic acid improves the phenotype of model mouse. N-Acetylneuraminic Acid glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Mus musculus